Floatz logo

Calcium folinate pentahydrate

Clear Cell Renal Carcinoma

Arkadiusz Z. Dudek, MDSmall moleculePhase 1/2Dormant
CCC
50/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
89/ 100

Competitive context

7 Active assets in the Clear Cell Renal Carcinoma cohort.

Asset / SponsorPhaseRating
Everolimus
Peking University First Hospital
Phase 2BB
Axitinib
University of California, San Francisco
Phase 3B
MODIFIED VACCINIA VIRUS ANKARA-5T4 ANTIGEN
Oxford BioMedica
Phase 3B
Toripalimab
RenJi Hospital
Phase 2B
Denosumab
Kelly Fitzgerald, MD
Phase 2CCC

View all 15 →

Same molecule, other indications

Calcium folinate pentahydrate is also rated in:

Advanced KRAS Positive Metastatic Colorectal CancerDormant
BBB
Indicative ·
78 / 100
View asset →
Recurrent Pancreatic CarcinomaDormant
BBB
Indicative ·
78 / 100
View asset →
Stage IV Colon CancerDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →